Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection

0301 basic medicine Proteínas de la Membrana Bacteriana Externa Porinas General Physics and Astronomy Bacterial Outer Membrane Proteins/genetics Choque Hemorrágico Proteínas de Transporte de Membrana Drug Resistance, Multiple, Bacterial Porins/genetics Membrane Transport Proteins/genetics Respiratory Tract Infections Plasmids/genetics Farmacorresistencia Bacteriana Múltiple Persona de Mediana Edad Research Support, Non-U.S. Gov't Q Infecciones por Pseudomonas Plásmidos Middle Aged Humanos Anti-Bacterial Agents 3. Good health Antibacterianos Pseudomonas Infections/drug therapy Pseudomonas aeruginosa Proteínas Bacterianas Engineering sciences. Technology Bacterial Outer Membrane Proteins Plasmids Respiratory Tract Infections/diagnosis Hydro-Lyases/genetics Science General Biochemistry,Genetics and Molecular Biology Análisis de Secuencia de ADN Porins Microbial Sensitivity Tests Shock, Hemorrhagic Pseudomonas aeruginosa/drug effects Article Meropenem/therapeutic use Selection, Genetic/genetics Selección Genética 03 medical and health sciences Bacterial Proteins Journal Article Humans Pseudomonas Infections Selection, Genetic Hydro-Lyases Bacterial Proteins/genetics Hidroliasas Infecciones del Sistema Respiratorio Membrane Transport Proteins General Chemistry Meropenem Sequence Analysis, DNA Drug Resistance, Multiple, Bacterial/genetics Anti-Bacterial Agents/therapeutic use Shock, Hemorrhagic/microbiology Human medicine Pruebas de Sensibilidad Microbiana
DOI: 10.1038/s41467-021-22814-9 Publication Date: 2021-04-28T10:10:35Z
ABSTRACT
AbstractIt is well established that antibiotic treatment selects for resistance, but the dynamics of this process during infections are poorly understood. Here we map the responses ofPseudomonas aeruginosato treatment in high definition during a lung infection of a single ICU patient. Host immunity and antibiotic therapy with meropenem suppressedP. aeruginosa, but a second wave of infection emerged due to the growth ofoprDandwbpMmeropenem resistant mutants that evolved in situ. Selection then led to a loss of resistance by decreasing the prevalence of low fitnessoprDmutants, increasing the frequency of high fitness mutants lacking the MexAB-OprM efflux pump, and decreasing the copy number of a multidrug resistance plasmid. Ultimately, host immunity suppressedwbpMmutants with high meropenem resistance and fitness. Our study highlights how natural selection and host immunity interact to drive both the rapid rise, and fall, of resistance during infection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (99)
CITATIONS (60)